化合物Teneligliptin hydrobromide T6999
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 906093-29-6 | ¥1,090.00 | 询底价 |
10 mg | 906093-29-6 | ¥397.00 | 询底价 |
25 mg | 906093-29-6 | ¥716.00 | 询底价 |
200 mg | 906093-29-6 | ¥2,420.00 | 询底价 |
5 mg | 906093-29-6 | ¥279.00 | 询底价 |
100 mg | 906093-29-6 | ¥1,630.00 | 询底价 |
500 mg | 906093-29-6 | ¥3,930.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Teneligliptin hydrobromide
描述: Teneligliptin hydrobromide (MP-513(hydrobromide)) 是β2肾上腺素能受体 (β2AR) 阻滞剂,具有抗高血压、抗氧化、清除自由基的活性。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (79.51 mM)
Ethanol : 17 mg/mL (27.03 mM)
H2O : 100 mg/mL (159.01 mM)
关键字: Teneligliptin | Teneligliptin Hydrobromide | MP 513 | Dipeptidyl Peptidase | MP-513 | Teneligliptin hydrobromide | DPP | Inhibitor | inhibit | MP513
相关产品: Trelagliptin succinate | RA190 | M3258 | NDMC101 | PR 39 (porcine) acetate | (1S,2S)-Bortezomib | MG-115 | MDL-28170 | PI-1840 | Linagliptin
相关库: Drug Repurposing Compound Library | HIF-1 Signaling Pathway Compound Library | Approved Drug Library | ReFRAME Related Library | Oxidation-Reduction Compound Library | Ferroptosis Compound Library | Inhibitor Library | Orally Active Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物Teneligliptin hydrobromide T6999信息由TargetMol中国为您提供,如您想了解更多关于化合物Teneligliptin hydrobromide T6999报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途